Monitoring method and device, monitoring equipment and storage medium

The monitoring method and device provide real-time tracking and automatic analysis of physiological sign parameters, addressing the challenge of manual retrieval and analysis in existing systems by using a tracking task display area with features like task sorting and automatic creation, enhancing efficiency and accuracy in medication stage monitoring.

CN119055189APending Publication Date: 2024-12-03EDAN INSTR
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202310652247.0
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2023-06-02
Publication Date
2024-12-03

AI Technical Summary

Technical Problem

Existing medical monitoring systems struggle to automatically analyze and track the dynamic changes of physiological sign parameters during the medication stage in real time, requiring manual retrieval and analysis, which is time-consuming and difficult to manage.

Method used

A monitoring method and device that includes a tracking task display area, allowing for the selection, execution, and display of tracking tasks, along with real-time analysis of physiological sign parameters, and supports features like task sorting, pausing, association, and automatic creation based on templates or external device instructions.

Benefits of technology

Enables real-time tracking and automatic analysis of physiological sign parameters, reducing manual workload and facilitating intuitive understanding of dynamic changes, ensuring tracking integrity and accuracy during medication stages.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN119055189A_ABST
    Figure CN119055189A_ABST
Patent Text Reader

Abstract

The invention relates to the technical field of medical electronic equipment, and discloses a monitoring method and device, monitoring equipment and a storage medium, and the method comprises the steps: displaying a monitoring interface of a drug tracking task, the monitoring interface comprising a tracking task display area and a tracking task data display area; determining a target tracking task in response to a selection operation and / or a creation operation on the tracking task; in response to a starting operation on the target tracking task, executing the target tracking task based on the starting operation; acquiring a physiological sign parameter of the monitored object for the target tracking task, and analyzing the physiological sign parameter to obtain a tracking analysis result; and displaying a tracking analysis result in a tracking task data display area. By implementing the method and the system, real-time tracking and automatic analysis of the physiological sign parameters are realized, and the tracking analysis result can be displayed in real time, so that medical staff can intuitively know the change dynamic state of the physiological sign parameters in the medication stage.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention relates to the technical field of medical electronic equipment, and in particular to a monitoring method, a device, a monitoring device and a storage medium. Background Art

[0002] With the development of computer technology, more and more medical electronic devices are used to analyze medical data, such as monitors for physiological sign parameters. Due to individual physiological differences among different patients, their physiological sign parameters will change under the effect of the drug after the patient takes the drug. Doctors can use the trend review function of the monitor to view the changes in the patient's vital signs during the treatment process, thereby evaluating the effectiveness of the drug treatment plan.

[0003] Although the monitors in the related art can combine the trend review of physiological sign parameters with event marking, that is, marking the medication records in the trend review interface, medical staff are required to manually retrieve physiological abnormal events during the treatment phase from the trend data, manually count the physiological changes during the entire medication phase, record physiological abnormalities, and determine and calculate the drug onset time, which takes a lot of time. In addition, it is difficult to track the dynamic changes of physiological sign parameters during the medication phase in real time based on the retrospective analysis of the patient's historical data. Summary of the invention

[0004] In view of this, the embodiments of the present invention provide a monitoring method, apparatus, monitoring device and storage medium to solve the problem that it is difficult to automatically analyze and track the dynamic changes of physiological sign parameters during the medication stage in real time.

[0005] In a first aspect, an embodiment of the present invention provides a monitoring method for use in a monitoring device, the method comprising: displaying a monitoring interface for a drug tracking task, the monitoring interface comprising a tracking task display area and a tracking task data display area, the tracking task display area comprising at least one group of tracking tasks; determining a target tracking task in response to a selection operation and / or a creation operation on a tracking task; executing the target tracking task based on the start operation in response to a start operation on the target tracking task; acquiring physiological sign parameters of a monitored object for the target tracking task, analyzing the physiological sign parameters, and obtaining tracking analysis results; and displaying the tracking analysis results in the tracking task data display area.

[0006] The monitoring method provided by the embodiment of the present invention displays the tracking task for the monitored object in the tracking task display area of ​​the monitoring interface, obtains the physiological sign parameters corresponding to the target tracking task in real time by selecting the target tracking task, and analyzes the physiological sign parameters to obtain the drug tracking analysis results, thereby avoiding manual retrieval and manual statistics of physiological abnormal events, and realizing real-time tracking of physiological sign parameters and automatic analysis of physiological sign parameters. At the same time, the tracking analysis results are displayed in the tracking task data display area, which is convenient for medical staff to intuitively understand the dynamic changes of physiological sign parameters during the medication stage.

[0007] In combination with the first aspect, in one implementation, the tracking task display area includes a sorting control, and the method further includes: in response to a first trigger operation on the sorting control, updating the display order of each group of tracking tasks based on the first trigger operation.

[0008] The monitoring method provided by the embodiment of the present invention supports adjusting the display order of tracking tasks to adapt to the usage habits of medical personnel, so that medical personnel can quickly retrieve the target tracking task from the tracking task display area.

[0009] In combination with the first aspect or its corresponding embodiment, in one embodiment, the tracking task display area also includes a task start and stop control, and the method also includes: when the target tracking task is in a tracking state, in response to a second trigger operation on the task start and stop control, pausing the target tracking task based on the second trigger operation; when the target tracking task is in a paused state, in response to a third trigger operation on the task start and stop control, starting the target tracking task based on the third trigger operation.

[0010] The monitoring method provided in the embodiment of the present invention supports the start / pause control of the target tracking task, thereby being able to flexibly control the tracking task in the event of patient transfer, short-term absence from the monitoring environment, or short-term interruption of monitoring, thereby ensuring the tracking integrity and accuracy of the physiological sign parameters during the medication stage to the greatest extent.

[0011] In combination with the first aspect or its corresponding embodiment, in one embodiment, the tracking task display area also includes a task association control, and the method also includes: in response to a fourth trigger operation on the task association control, displaying an association creation interface based on the fourth trigger operation, wherein at least one task to be associated is displayed in the association creation interface; in response to a selection operation on the task to be associated, determining a target association task from at least one task to be associated; bidirectionally binding the target association task with the target tracking task; displaying the target tracking task and the target association task in the tracking task display area according to a preset arrangement order, and displaying the tracking data of the target tracking task and the target association task in the tracking task data display area.

[0012] The monitoring method provided by the embodiment of the present invention supports the association of multiple tracking tasks. By setting a binding relationship between a target tracking task and a target association task, the tracking data of the target tracking task and the target association task are displayed in a tracking task data display area, thereby facilitating the joint analysis of changes in physiological sign parameters during overlapping medication stages.

[0013] In combination with the first aspect or its corresponding embodiment, in one embodiment, the method also includes: in response to a disassociation operation of a target association task and a target tracking task, unbinding the target association task from the target tracking task based on the disassociation operation; updating the associated tasks of the target tracking task, and updating the tracking data displayed in the tracking task data display area.

[0014] The monitoring method provided by the embodiment of the present invention supports the removal of the association between the target tracking task and the target association task when there is no medication association between the target association task and the target tracking task, thereby ensuring the effectiveness of monitoring vital sign parameters.

[0015] In combination with the first aspect, in one embodiment, the tracking task display area includes a task creation control; in response to the creation operation of the tracking task, the target tracking task is determined, including: in response to the fifth trigger operation of the task creation control, the tracking task creation interface is displayed based on the fifth trigger operation, and the tracking task creation interface includes multiple parameter editing areas; in response to the input operation of each parameter editing area, the tracking task parameters are determined based on the input operation; the target tracking task is created based on the tracking task parameters, and the target tracking task is displayed in the tracking task display area.

[0016] The monitoring method provided by the embodiment of the present invention supports the creation of target tracking tasks, facilitates medical staff to set tracking tasks for medication stages according to actual medication situations, and realizes flexible creation of tracking tasks.

[0017] In combination with the first aspect or its corresponding embodiment, in one embodiment, the method further includes: in response to a template selection operation in the parameter editing area, determining a target creation template for the tracking task based on the template selection operation.

[0018] The monitoring method provided by the embodiment of the present invention has a template set in the parameter editing area, which supports the direct creation of tracking tasks according to the template, so that medical staff can quickly create and start tracking tasks, reducing cumbersome input operations.

[0019] In combination with the first aspect or its corresponding embodiment, in one embodiment, the method also includes: receiving a creation instruction for a tracking task sent by an external device, the external device is communicatively connected with the monitoring device; obtaining drug infusion information corresponding to the creation instruction and attribute information of the monitored object, the drug infusion information is associated with the attribute information; obtaining a drug tracking template based on the creation instruction, and using the drug tracking template to create a target tracking task for the monitored object and drug infusion information.

[0020] The monitoring method provided in the embodiment of the present invention receives a creation instruction sent by an external device, obtains corresponding drug infusion information and attribute information of the monitored object, and creates a target tracking task, thereby realizing automatic creation of the target tracking task.

[0021] In combination with the first aspect or its corresponding embodiment, in one embodiment, the physiological sign parameters of the monitored object for the target tracking task are obtained, and the physiological sign parameters are analyzed to obtain the drug tracking analysis results, including: analyzing the changing trends of the physiological sign parameters to determine the fluctuation data of the physiological sign parameters; analyzing the fluctuation data within a preset tracking time to determine the abnormal data and standard data of the physiological sign parameters; weighting the abnormal data and standard data to generate the tracking analysis results.

[0022] The monitoring method provided by the embodiment of the present invention analyzes the changing trend of physiological sign parameters to obtain corresponding fluctuation data, and can count abnormal data and standard data within a preset tracking time in combination with the fluctuation data, and then perform weighted statistics on the abnormal data and standard data to obtain corresponding tracking analysis results. In this way, the influence of multiple parameters on physiological sign parameters can be evaluated, and the changing state of physiological sign parameters during the medication stage can be described through the tracking analysis results, thereby realizing automatic analysis of physiological sign parameters, which is convenient for medical staff to evaluate the effectiveness of the current medication for the monitored object.

[0023] In combination with the first aspect or its corresponding embodiment, in one embodiment, the tracking task data display area includes a tracking trend display area and a tracking data display area, and the tracking analysis results are displayed in the tracking task data display area, including: displaying the tracking analysis results in digital form in the tracking data display area; displaying the tracking analysis results in graphical form in the tracking trend display area.

[0024] The monitoring method provided by the embodiment of the present invention supports digital display and graphical display of tracking and analysis results, which is convenient for medical personnel to analyze the physiological state of the monitored object from quantitative and qualitative perspectives respectively.

[0025] In combination with the first aspect or its corresponding embodiment, in one embodiment, the tracking trend display area includes a baseline control, and the method also includes: in response to a start operation or a close operation of the baseline control, displaying the tracking baseline in the tracking trend display area based on the start operation, or hiding the tracking baseline in the tracking trend display area based on the close operation.

[0026] The monitoring method provided in the embodiment of the present invention supports turning on and off the tracking baseline, so that medical staff can intuitively understand the changing status of physiological sign parameters by tracking the baseline.

[0027] In combination with the first aspect or its corresponding embodiment, in one embodiment, the trend tracking display area includes a cursor control, and the method also includes: in response to a move operation on the cursor control, determining the target monitoring point where the cursor is currently located based on the move operation; and displaying the target parameter value corresponding to the target monitoring point.

[0028] The monitoring method provided by the embodiment of the present invention determines the target parameter value of the target monitoring point by moving the cursor control, so that the medical staff can review the target parameter value corresponding to the target monitoring point.

[0029] In a second aspect, an embodiment of the present invention provides a monitoring system, the system comprising: a monitoring interface display module, used to display a monitoring interface of a drug tracking task, the monitoring interface comprising a tracking task display area and a tracking task data display area, the tracking task display area comprising at least one group of tracking tasks; a task creation module, used to determine a target tracking task in response to a selection operation and / or a creation operation of a tracking task; a task start module, used to respond to a start operation of a target tracking task and execute the target tracking task based on the start operation; a parameter monitoring module, used to obtain the physiological sign parameters of the monitored object for the target tracking task, analyze the physiological sign parameters, and obtain a drug tracking analysis result; a tracking result display module, used to display the tracking analysis result in the tracking task data display area in the monitoring interface.

[0030] In a third aspect, an embodiment of the present invention provides a monitoring device, comprising: a memory and a processor, the memory and the processor are communicatively connected to each other, computer instructions are stored in the memory, and the processor executes the monitoring method of the first aspect or any corresponding embodiment thereof by executing the computer instructions.

[0031] In a fourth aspect, an embodiment of the present invention provides a computer-readable storage medium having computer instructions stored thereon, the computer instructions being used to enable a computer to execute the monitoring method of the first aspect or any corresponding embodiment thereof. BRIEF DESCRIPTION OF THE DRAWINGS

[0032] In order to more clearly illustrate the specific implementation methods of the present invention or the technical solutions in the prior art, the drawings required for use in the specific implementation methods or the description of the prior art will be briefly introduced below. Obviously, the drawings described below are some implementation methods of the present invention. For ordinary technicians in this field, other drawings can be obtained based on these drawings without paying creative work.

[0033] Figure 1 is a schematic diagram of the hardware structure of a monitoring device according to an embodiment of the present invention;

[0034] Figure 2 is a flowchart of a monitoring method according to some embodiments of the present invention;

[0035] Figure 3 is a schematic diagram of a monitoring interface according to some embodiments of the present invention;

[0036] Figure 4 is a flow chart of another monitoring method according to some embodiments of the present invention;

[0037] Figure 5 is a schematic diagram of a tracking task creation interface according to some embodiments of the present invention;

[0038] Figure 6 is a schematic diagram of a histogram of a tracking trend graph according to some embodiments of the present invention;

[0039] Figure 7 is a schematic diagram of a distribution diagram of a tracking trend graph according to some embodiments of the present invention;

[0040] Figure 8 4 is a structural block diagram of a monitoring device according to an embodiment of the present invention. DETAILED DESCRIPTION

[0041] In order to make the purpose, technical solution and advantages of the embodiments of the present invention clearer, the technical solution in the embodiments of the present invention will be clearly and completely described below in conjunction with the drawings in the embodiments of the present invention. Obviously, the described embodiments are part of the embodiments of the present invention, not all of the embodiments. Based on the embodiments of the present invention, all other embodiments obtained by those skilled in the art without creative work are within the scope of protection of the present invention.

[0042] Drug treatment and efficacy evaluation are important parts of clinical treatment evaluation. Medical staff can observe and monitor changes in vital signs to determine whether the medication is effective. However, different patients have individual physiological differences. After taking medication, their physiological sign parameters will change differently under the effect of the drug.

[0043] Monitors in related technologies support marking medication records in the trend review interface. If medical staff want to locate the therapeutic effect of a certain drug, they can first retrieve medication events from the trend data of the patient's entire course of illness, and then look back at the trend of physiological parameter changes based on the medication events. However, this method is not convenient for long-term monitoring of drug efficacy. The longer the observation time, the longer the time span of trend data that medical staff need to manually review. Manually counting physiological changes during the entire medication stage, recording physiological abnormalities, and judging and calculating the drug onset time greatly increases the workload and difficulty of medical staff.

[0044] At the same time, for patients who take combined medications or medications in stages, medical staff need to review and analyze physiological sign parameters based on the patient's historical data, and compare the changes in multiple physiological sign parameters in multiple stages. As a result, the monitoring method in the relevant technology is difficult to observe the dynamics of physiological sign parameters during the medication stage in real time, making it difficult for medical staff to directly obtain relevant information about the medication stage through the monitor display interface.

[0045] According to an embodiment of the present invention, a monitoring device is provided, referring to Figure 1 The structural block diagram of the monitoring device shown in the figure. The monitoring device includes at least a processor 110 and a memory 140, and interfaces for connecting various components, including high-speed interfaces and low-speed interfaces. The various components are connected to each other using different buses for communication, and can be installed on a common motherboard or installed in other ways as needed. The processor can process instructions executed in the computer device, including instructions stored in or on the memory to display graphical information of the GUI on an external input / output device (such as a display device coupled to the interface).

[0046] In some optional embodiments, if desired, multiple processors and / or multiple buses can be used together with multiple memories and multiple memories. Similarly, multiple computer devices can be connected, and each device provides part of the necessary operations (for example, as a server array, a group of blade servers, or a multi-processor system). Figure 1 A processor 110 is taken as an example. The processor 110 may be a central processing unit, a network processor or a combination thereof. The processor 110 may further include a hardware chip. The hardware chip may be a dedicated integrated circuit, a programmable logic device or a combination thereof. The programmable logic device may be a complex programmable logic device, a field programmable logic gate array, a general purpose array logic or any combination thereof.

[0047] The memory 140 stores instructions executable by at least one processor 110, so that at least one processor 110 executes the monitoring method shown in the following embodiment.

[0048] The memory 140 may include a program storage area and a data storage area, wherein the program storage area may store an operating system and an application required by at least one function; the data storage area may store data created according to the use of the monitoring device, such as patient monitoring data, alarm event information, version information, etc. during the operation of the monitoring device, and the storage format may be a picture format, a document format, a table format, or a compressed file format. The storage content of the data storage area is read and written by the processor 110. In addition, the memory 140 may include a high-speed random access memory, and may also include a non-transient memory, such as at least one disk storage device, a flash memory device, or other non-transient solid-state storage device. In some optional embodiments, the memory 140 may optionally include a memory remotely arranged relative to the processor 110, and these remote memories may be connected to the monitoring device via a network. Examples of the above-mentioned network include, but are not limited to, the Internet, an intranet, a local area network, a mobile communication network, and a combination thereof.

[0049] The memory 140 may include a volatile memory, such as a random access memory; the memory may also include a non-volatile memory, such as a flash memory, a hard disk or a solid state drive; the memory 140 may also include a combination of the above types of memory.

[0050] The monitoring device further includes a parameter measuring device 120 , a display device 130 , an alarm device 150 , a timer 160 , and a communication interface 170 .

[0051] Monitoring equipment includes but is not limited to bedside monitors, telemetry wearable monitors, central management systems, etc. In this embodiment, the bedside monitor is taken as an example, and the processor 110 executes the monitor main program and coordinates and controls the work between various devices. The parameter measurement device 120 is used to collect physiological parameter signals of the monitored object, and the physiological parameters include but are not limited to electrocardiogram, blood oxygen, and blood pressure parameters. The display device 130 is a display, including but not limited to a liquid crystal display, a light-emitting diode, a display and a plasma display. In some optional embodiments, the display device 130 can be a touch screen. The processor 110 controls the display content and responds to the display effect switching, provides a visual display interface, including but not limited to a list, a trend chart, a trend table, and a state distribution chart, and provides a graphical instruction entry. The processor 110 monitors the action instructions and runs the relevant program. The alarm device 150 can receive the parameter alarm information of the parameter measurement device 120, trigger the alarm state by sound, light text, etc., and indicate the physiological abnormality of the monitored object or the abnormal operation of the monitoring equipment, so that medical staff can perform corresponding rescue and treatment measures. The timer 160 can respond to the timing instruction initiated by the processor 110 to record the cumulative duration of the medical operation.

[0052] In some real-time examples, the data source of the monitoring device can also exchange data with external devices through wired or wireless transmission to obtain data from external devices. The above-mentioned communication interface 170 is used for communication between the monitoring device and other devices or communication networks to obtain data from external devices. Among them, wireless communication technologies include but are not limited to: various generations of mobile communication technologies (2G, 3G, 4G and 5G), wireless networks, Bluetooth, ZigBee, UltraWide Band (UWB), Near Field Communication (NFC), etc.

[0053] The monitoring device may also include an input device and an output device. The processor 110, the memory 140, the input device and the output device may be connected via a bus or other means.

[0054] The input device can receive input digital or character information and generate key signal input related to the user settings and function control of the computer device, such as a touch screen, a keypad, a mouse, a track pad, a touch pad, a pointer, one or more mouse buttons, a track ball, a joystick, etc. The output device can include an auxiliary lighting device (e.g., an LED) and a tactile feedback device (e.g., a vibration motor), etc.

[0055] Figure 1 This is only an example of a component of a monitoring device. In some specific embodiments, the components of the monitoring device are not limited and may include Figure 1 More or fewer components.

[0056] The embodiment of the present invention is based on Figure 1 The processor 110 is a component structure. When the processor 110 monitors the tracking instruction from the display device 130, it starts the tracking task of the medication stage and synchronously starts the working state of the timer 160. The processor 110 obtains the parameter value of the physiological sign parameter of the monitored object from the parameter measurement device 120. During the monitoring process of the physiological sign parameter, the alarm device 150 monitors in real time whether the parameter value of the physiological sign parameter is abnormal. When the parameter value is abnormal, it immediately triggers and outputs the alarm signal. The memory 140 records the parameter value and alarm event of the physiological sign parameter during the monitoring process. The processor 110 receives the trigger instruction of the timer 160, counts the tracking and analysis results for the medication stage within a preset time period, and provides the tracking and analysis results to the medical staff through the monitoring interface of the display device, so that the medical staff can intuitively understand the physiological state of the monitored object in the medication stage, and provide theoretical data support for formulating or adjusting medication.

[0057] According to an embodiment of the present invention, a monitoring method embodiment is provided. It should be noted that the steps shown in the flowchart of the accompanying drawings can be executed in a computer system such as a set of computer executable instructions, and although a logical order is shown in the flowchart, in some cases, the steps shown or described can be executed in an order different from that shown here.

[0058] In this embodiment, a monitoring method is provided, which can be used for the above-mentioned monitoring device. Figure 2 is a flow chart of a monitoring method according to an embodiment of the present invention. Figure 2 As shown, the process includes the following steps:

[0059] Step S101, displaying a monitoring interface of a drug tracking task, the monitoring interface including a tracking task display area and a tracking task data display area, the tracking task display area including at least one group of tracking tasks.

[0060] The monitoring interface is used to display the monitoring data of the physiological signs and parameters generated by the monitored object during the medication phase. Figure 3 As shown, the monitoring interface includes a tracking task display area 20 and a tracking task data display area 21. The tracking task display area 20 is used to display one or more groups of tracking tasks for the monitored object.

[0061] The tracking task data display area 21 is used to display the tracking information of the physiological sign parameters of the monitored object corresponding to the tracking task in real time. Among them, the tracking task is a drug tracking task for the monitored object during the medication stage created by medical staff or monitoring equipment, through which the physiological sign parameters of the medication stage are tracked and recorded in real time.

[0062] The display content of the tracking task includes, but is not limited to, tracking task information, tracking status, related associated tasks, etc. The tracking task information may specifically include detailed information of the tracking task, such as task title, target stage, parameter values ​​and target values ​​corresponding to each target stage, etc. Information related to the tracking status may be task start time, task end time, current working status of the task, etc. The display content and presentation form of each group of tracking tasks may be adjusted according to specific needs and the display space size of the tracking task display area 20, or replaced by corresponding abbreviation codes.

[0063] Step S102: determining a target tracking task in response to a selection operation and / or a creation operation on a tracking task.

[0064] The medical staff retrieves the target tracking task they need from one or more groups of tracking tasks displayed in the tracking task display area 20. Accordingly, the monitoring device can respond to the medical staff's selection operation on the tracking task and determine the target tracking task selected by the medical staff.

[0065] If the medical staff does not retrieve the target tracking task they need in the tracking task display area 20, they can create the target tracking task they need in the tracking task display area 20. Accordingly, the monitoring device can respond to the creation operation of the medical staff and display a tracking task creation page so that the medical staff can create the target tracking task in the tracking task creation page. After the creation of the target tracking task is completed, the target tracking task will be displayed in the tracking task display area 20.

[0066] Step S103, in response to the start operation of the target tracking task, executing the target tracking task based on the start operation.

[0067] The medical staff starts the target tracking task, and accordingly, the monitoring device can respond to the start operation and execute the start instruction of the target tracking task. At this time, the target tracking task will be executed in the monitoring setting.

[0068] Step S104, obtaining physiological sign parameters of the monitored object for the target tracking task, analyzing the physiological sign parameters, and obtaining tracking analysis results.

[0069] During the execution of the target tracking task, the parameter measuring device in the monitoring equipment will automatically obtain the physiological sign parameters of the monitored object corresponding to the target tracking task, and display them in real time in the tracking task data display area.

[0070] Analyze the physiological sign parameters, calculate the drug onset time and count the abnormal physiological events during medication according to the changing trend of the physiological sign parameters, and comprehensively evaluate the current medication stage of the monitored object by combining the drug onset time, the changing status of the physiological sign parameters and the number of abnormal physiological events, and generate corresponding tracking analysis results.

[0071] Among them, the drug onset time refers to the time from the start of the target tracking task to the time when the physiological sign parameters first reach the standard; physiological abnormal events include: physiological alarms of parameter value exceeding the limit, arrhythmia alarms, suffocation alarms and other life alarms. The monitoring equipment will generate alarm information and alarm signals to remind medical staff to take corresponding treatment measures.

[0072] Step S105: display the tracking analysis results in the tracking task data display area.

[0073] The monitoring device outputs the tracking analysis results and displays them in the tracking task data display area 21 of the monitoring interface. At the same time, the tracking task data display area 21 displays the trend curve of the physiological sign parameters, and supports reviewing the physiological sign parameter values ​​at any time within the tracking time interval.

[0074] The monitoring method provided in this embodiment displays the tracking task for the monitored object in the tracking task display area of ​​the monitoring interface, and obtains the physiological sign parameters corresponding to the target tracking task in real time by selecting the target tracking task, and analyzes the physiological sign parameters to obtain the drug tracking analysis results, thereby avoiding manual retrieval and manual statistics of physiological abnormal events, and realizing real-time tracking of physiological sign parameters and automatic analysis of physiological sign parameters. At the same time, the tracking analysis results are displayed in the tracking task data display area, which is convenient for medical staff to intuitively understand the dynamic changes of physiological sign parameters during the medication stage.

[0075] In some optional implementations, a sorting control is provided in the tracking task display area. Accordingly, the monitoring method may further include: in response to a first trigger operation on the sorting control, updating the display order of each group of tracking tasks based on the first trigger operation.

[0076] The tracking task display area can display all tracking tasks and the status of the tracking tasks of the current monitoring object in a list form, and all tracking tasks of the monitoring object are arranged in a pre-set order. Each row in the tracking task list represents a group of tracking tasks.

[0077] Specifically, a sorting control 201 is provided in the tracking task display area, and the display order of the tracking tasks can be switched and updated through the sorting control 201. The switching method includes but is not limited to the order of the start time of the tracking tasks, the level of the tracking tasks, the type of the tracking tasks, etc.

[0078] The tracking tasks of the monitored object are displayed here in a list form to facilitate medical staff to read all tracking tasks of the current monitored object. At the same time, multiple list switching methods can be provided to adjust the display order of the tracking tasks to adapt to the usage habits of medical staff, so that medical staff can quickly retrieve the target tracking tasks from the tracking task display area.

[0079] In some optional implementations, a task start and stop control is provided in the tracking task display area. Accordingly, the monitoring method may further include:

[0080] Step A1: when the target tracking task is in the tracking state, in response to a second trigger operation on the task start / stop control, pausing the target tracking task based on the second trigger operation.

[0081] Step A2: when the target tracking task is in a paused state, in response to a third trigger operation on the task start / stop control, starting the target tracking task based on the third trigger operation.

[0082] The tracking task display area 20 is provided with a task start and stop control 204, such as Figure 3As shown. The task start-stop control 204 is used to control the start or pause of the target tracking task. Specifically, when the target tracking task is in the tracking state, the task start-stop control 204 is triggered, and the monitoring device will respond to the trigger operation and suspend the execution of the target tracking task; when the target tracking task is in the paused state, the task start-stop control 204 is triggered, and the monitoring device will respond to the trigger operation and restart the execution of the target tracking task.

[0083] Therefore, when the monitored object transfers to the monitoring environment, leaves the monitoring environment for a short time, or performs other medical operations and interrupts the monitoring for a short time, the target tracking task can be flexibly controlled to be paused and started, which can ensure the tracking integrity of the medication stage to the greatest extent. In addition, the data of the paused tracking period is not used as the data source of the medication stage, which can ensure the accuracy of drug tracking in the medication stage to the greatest extent.

[0084] In some optional implementations, a task association control is provided in the tracking task display area. Accordingly, the monitoring method may further include:

[0085] Step B1, in response to a fourth trigger operation on a task association control, displaying an association creation interface based on the fourth trigger operation, wherein at least one task to be associated is displayed in the association creation interface.

[0086] Step B2: in response to a selection operation on a task to be associated, determining a target associated task from at least one task to be associated.

[0087] Step B3, bidirectionally bind the target association task and the target tracking task.

[0088] Step B4, displaying the target tracking task and the target association task in the tracking task display area according to a preset arrangement order, and displaying the tracking data of the target tracking task and the target association task in the tracking task data display area.

[0089] The medication stage is a transition stage of the vital signs of the monitored object. During this stage, there is overlapping medication for a certain period of time. During the overlapping medication stage, it is necessary to closely monitor the various physiological sign parameters used to characterize vital signs and the functional changes of target organs.

[0090] In this embodiment, a task association control 202 is provided in the tracking task display area 20, and the task association control 202 provides the tracking task association function, that is, setting the association binding relationship between the target tracking task and other tracking tasks. The association binding relationship can be one-to-one or one-to-many, and the two groups of tracking tasks with an associated binding relationship support viewing the associated tracking task details in their respective tracking task data display areas 21.

[0091] Specifically, after the medical staff selects the target tracking task, the creation of the associated task can be triggered through the task association control 202. Accordingly, the monitoring device can respond to the creation instruction and enter the association creation interface. At least one task to be associated is displayed in the association creation interface, and the tasks to be associated can be displayed in the form of a list. The medical staff can select the desired target associated task from the list of tasks to be associated, and accordingly, the monitoring device can establish an association relationship between the target tracking task and the target associated task based on the creation instruction.

[0092] The target tracking task and the target association task that have successfully established an association binding relationship support a two-way display of the association relationship between the two. That is, the association binding relationship is bidirectionally synchronized. For example, after creating an association binding relationship between target tracking task A and target association task B (target association task B is actually another set of tracking tasks for the monitored object), the association creation interface of target association task B will synchronously display the association relationship with target tracking task A.

[0093] The two sets of tracking tasks in the associated binding state support joint analysis. Specifically, multiple tracking tasks are displayed simultaneously in the tracking task data display area 21, and the tracking task data display area 21 is displayed in the order of main task (i.e., target tracking task) as the first and associated task (i.e., target associated task) as the second.

[0094] It should be noted that here you can select multiple target tracking tasks to create associated tasks, but target tracking tasks that are already in an associated binding relationship do not support repeated binding.

[0095] The monitoring method provided in this embodiment supports the association of multiple tracking tasks. By setting a binding relationship between a target tracking task and a target association task, the tracking data of the target tracking task and the target association task are displayed in a tracking task data display area, thereby facilitating the joint analysis of changes in physiological sign parameters during overlapping medication stages.

[0096] In some optional implementations, the above monitoring method may further include:

[0097] Step B5, in response to the de-association operation on the target association task and the target tracking task, the target association task and the target tracking task are untied based on the de-association operation.

[0098] Step B6, updating the associated tasks of the target tracking task, and updating the tracking data displayed in the tracking task data display area.

[0099] The method also supports initiating an association removal instruction at any one party in the pairwise association, and the target association task to be removed from the tracking task data display area 20 corresponding to the target tracking task.

[0100] Specifically, the medical staff can select the target tracking task, click the task association control 202, trigger the association release instruction, and enter the association release page. Then, in response to the medical staff's selection of the associated task list, the tracking task to be associated is determined, and the association release instruction is executed. While responding to the association release instruction, the associated lists of both parties' tasks are updated, and the tracking data displayed in the corresponding tracking task data display area 20 of both parties are refreshed.

[0101] Therefore, when there is no medication association between the target association task and the target tracking task, the association between the target tracking task and the target association task is supported to ensure the effectiveness of monitoring vital sign parameters.

[0102] In this embodiment, a monitoring method is provided, which can be used for the above-mentioned monitoring device. Figure 4 is a flow chart of a monitoring method according to an embodiment of the present invention. Figure 4 As shown, the process includes the following steps:

[0103] Step S201, displaying the monitoring interface of the drug tracking task, the monitoring interface includes a tracking task display area and a tracking task data display area, the tracking task display area includes at least one group of tracking tasks. For details, please refer to the relevant description of the corresponding steps in the above embodiment, which will not be repeated here.

[0104] Step S202: determining a target tracking task in response to a selection operation and / or a creation operation on a tracking task.

[0105] Specifically, a task creation control is provided in the tracking task display area. Accordingly, the above step S202 may include:

[0106] Step S2021, in response to the selection operation of the tracking task, determine the target tracking task. Please refer to the relevant description corresponding to the above embodiment for details, which will not be repeated here.

[0107] Step S2022: In response to the fifth trigger operation on the task creation control, a tracking task creation interface is displayed based on the fifth trigger operation, and the tracking task creation interface includes a plurality of parameter editing areas.

[0108] A task creation control 230 is provided in the tracking task display area 20. The medical staff can enter the tracking task creation interface by triggering the task creation control 230. Figure 5 As shown. The tracking task creation interface includes multiple parameter editing areas, each of which is used to set the parameters required for the tracking task. Specifically, the multiple parameter editing areas include a drug information editing area, a treatment target editing area, an abnormal event editing area, and the like.

[0109] Among them, the drug information editing area is used to obtain the drug information provided by the target tracking task tracking. Specifically, the drug information can be edited and input by medical staff. For medical staff to quickly input drug information, the drug information editing area can perform intelligent recognition when the drug is input, for example, automatically prompt the relevant drug name when entering the first letter, or provide commonly used drug options according to the disease type. The use of drugs supports users to edit or identify the drug type and automatically match the corresponding use method.

[0110] In some embodiments, the drug information may also be determined by acquiring information of an infusion pump connected to the monitoring device through the communication interface 170 .

[0111] The treatment target editing area is used to obtain key parameters for creating a target tracking task, which include the monitored physiological sign parameters, target parameter values, monitoring time, etc. The target parameter value can be set as a fixed value or an interval value, and the medication stage supports setting multiple stages. In some embodiments, the function of adding / deleting medication stages can also be provided here to meet the actual scenario of staged medication.

[0112] The abnormal event editing area is used to edit the source of the abnormal event, and the options of the abnormal event may include physiological alarm, fluctuation time, fatal physiological alarm light, etc. Of course, a default abnormal event type can be provided here according to the disease type of the monitored object.

[0113] Step S2023: In response to input operations on each parameter editing area, determining tracking task parameters based on the input operations.

[0114] The medical staff inputs relevant parameters in each parameter editing area according to actual needs. Accordingly, the monitoring device can respond to the input operation of the medical staff in each parameter editing area and generate corresponding tracking task parameters.

[0115] Step S2024: Create a target tracking task based on the tracking task parameters, and display the target tracking task in the tracking task display area.

[0116] After confirming the tracking task parameters, create a target tracking task according to the tracking task parameters, and display the created target tracking task on the Figure 3 The tracking task display area 20 is displayed.

[0117] In some optional implementations, a template option is provided in the parameter editing area. Accordingly, the above step S02 may further include: in response to a template selection operation in the parameter editing area, determining a target creation template for the tracking task based on the template selection operation.

[0118] like Figure 5As shown in the figure, there are commonly used template options in the parameter editing area. This module option is a pre-set template for creating tracking tasks, which is equivalent to a shortcut for creating target tracking tasks. By setting the template option, medical staff can directly create corresponding target tracking tasks according to the template and start the tracking task, reducing tedious input operations.

[0119] In some optional implementations, medical personnel may also customize abnormal events in advance and save them as templates for subsequent use.

[0120] By setting a template in the parameter editing area, it supports the direct creation of tracking tasks according to the template, so that medical staff can quickly create and start tracking tasks, reducing tedious input operations.

[0121] Based on the above, the monitoring device can communicate with other external devices through the communication interface. In some optional implementations, the method of creating a target tracking task may also include:

[0122] Step C1, receiving a creation instruction for a tracking task sent by an external device, and the external device is connected to the monitoring device for communication.

[0123] Step C2, obtaining the drug infusion information corresponding to the creation instruction and the attribute information of the monitored object, wherein the drug infusion information is associated with the attribute information.

[0124] Step C3, obtaining a drug tracking template based on the creation instruction, and using the drug tracking template to create a target tracking task for the monitored object and drug infusion information.

[0125] When the monitoring device is equipped with the communication interface 170, the monitoring device can receive the creation instruction of the tracking task sent by the external device, and obtain the drug infusion information, such as the drug information, infusion speed, and estimated medication time of the infusion pump or the injection pump through the communication interface 170, for real-time display in the tracking task data display area 20. At the same time, the attribute information of the monitoring object bound to the drug infusion information is obtained through the communication interface 170, including the name, age, etc. of the monitoring object.

[0126] According to the creation instruction, the template corresponding to the current drug infusion information is called to automatically create a target tracking task for the monitored object. During the drug infusion tracking process, the external device sends the physiological sign parameters to the monitoring device in real time through the communication interface 170 so that the monitoring device can be updated synchronously.

[0127] Here, by receiving the creation instruction sent by the external device, the corresponding drug infusion information and the attribute information of the monitored object are obtained, and the target tracking task is created, thereby realizing the automatic creation of the target tracking task.

[0128] Step S203, in response to the start operation of the target tracking task, the target tracking task is executed based on the start operation. For details, please refer to the relevant description of the corresponding steps in the above embodiment, which will not be repeated here.

[0129] Step S204, obtaining physiological sign parameters of the monitored object for the target tracking task, analyzing the physiological sign parameters, and obtaining tracking analysis results.

[0130] Specifically, the above step S204 may include:

[0131] Step S2041, analyzing the changing trend of the physiological sign parameters to determine the fluctuation data of the physiological sign parameters.

[0132] After starting the target tracking task, the parameter measurement device 120 of the monitoring equipment automatically obtains the real-time monitoring values ​​of the physiological sign parameters of the monitored object, and the processor 110 can obtain the real-time monitoring values ​​of the physiological sign parameters from the parameter measurement device 120, and perform fluctuation analysis on the data trend of the real-time monitoring values ​​of the physiological sign parameters to obtain the fluctuation data of the physiological sign parameters.

[0133] Step S2042, analyzing the fluctuation data within the preset tracking time to determine the abnormal data and the standard data of the physiological sign parameters.

[0134] The preset tracking time is a preset tracking duration, and the fluctuation data within the preset tracking time is compared with the preset value of the physiological sign parameter to determine whether there is an abnormality. When there is an abnormality, the alarm device 150 generates an alarm. The processor 110 can count the number of abnormal events generated within the preset tracking time to determine the abnormal data of the physiological sign parameter, and the abnormal data includes the alarm time, the sudden change value of the physiological sign parameter, etc. And obtain the target data of the physiological sign parameter through the timer 160, and the target data includes the first target time and the target maintenance time, etc.

[0135] Step S2043, weighting the abnormal data and the standard data to generate a tracking analysis result.

[0136] The fluctuation data, abnormal data and standard data obtained above are weighted and processed to calculate the physiological standard score value of the medication stage, and the standard score value supports real-time or scheduled updates. The physiological standard score value, abnormal data and standard data are combined as the tracking and analysis results. Among them, the weight value allocation of fluctuation data, abnormal data and standard data can be defined according to empirical values, which is not limited here.

[0137] Specifically, the closer the first target-reaching time is to the start time of the target tracking task, the higher the positive weight factor will be; the longer the target is maintained, the higher the positive weight factor will be. For situations where the target is not reached, a negative weight factor will be set. Similarly, the more abnormal events there are, the higher the negative weight factor will be. The smaller the coefficient of fluctuation of the fluctuation data, the higher the stability of the drug efficacy, and the higher the positive weight factor will be. Of course, the weighted statistical method may be different in a specific implementation method, but the higher the target-reaching score obtained by weighted processing, the better the target is reached, and the better the drug efficacy is. On the contrary, it means that the drug efficacy is worse.

[0138] Step S205: display the tracking analysis results in the tracking task data display area.

[0139] Specifically, the tracking task data display area includes a tracking trend display area and a tracking data display area. Accordingly, the above step S205 may include:

[0140] Step S2051, displaying the tracking analysis results in a digital form in the tracking data display area.

[0141] The tracking task data display area 21 shows an overview of all the tracking tasks currently existing in the monitored object, and the tracking task data display area 21 combines digitalization and graphics to present detailed information of the target tracking task. Specifically, the tracking task data display area 21 includes a tracking data display area 211 and a tracking trend display area 212, such as Figure 3 The tracking data display area 211 is used to display the tracking analysis results in a digital form, so as to analyze the physiological state of the monitored object from a quantitative perspective.

[0142] The tracking data display area 211 displays the current main information of the target tracking task and the calculated tracking analysis results. The current main information should be consistent with the tracking task display area 20 or have more detailed content information. Considering that the display space of the tracking data display area 211 is limited, the main information here can be replaced by corresponding abbreviation characters.

[0143] In some optional embodiments, the tracking data display area 211 is provided with an entrance for viewing the details of the target tracking task, which can be a pop-up window, a floating label, etc., to display all the information of the tracking task. The tracking analysis results are refreshed by the processor 110 within a preset time interval (e.g., 30s, 60s, etc.), and the tracking analysis results include: target time statistics, abnormal event statistics, target score, etc., which are not specifically limited here. The tracking analysis results displayed in digital form are mainly used to quantitatively describe the effectiveness of the current medication for the monitored object.

[0144] Specifically, the time to reach the target can be the time when the monitored physiological sign parameter reaches the target for the first time, or it can be the cumulative time that the physiological sign parameter reaches the target during the monitoring stage. In some specific implementations, the time to reach the target can be counted in stages, or comprehensive multi-stage statistics, which is not specifically limited here.

[0145] Specifically, the statistical basis of abnormal events can be that the monitored physiological sign parameters or other physiological sign parameters exceed the set safety threshold, or the fluctuation range of the monitored physiological sign parameters exceeds the preset threshold, and / or fatal or non-fatal physiological alarm events occur during the tracking period. Of course, the judgment and statistics of abnormal events can be a combination of multiple conditions, which depends on the situation of the monitored object and is not specifically limited here.

[0146] Step S2052, displaying the tracking analysis results in a graphical form in the tracking trend display area.

[0147] The tracking trend display area 212 is used to display the tracking analysis results in a graphical form to analyze the physiological state of the monitored object from a qualitative perspective.

[0148] Specifically, the tracking trend display area 212 intuitively reflects the dynamic physiological changes of the monitored object through the tracking trend graph to capture abnormal events generated by the monitored object in the current or historical time. Figure 3 As shown, the tracking trend graph displays the overall trend change of the monitored physiological sign parameters in the form of trend coordinates, and the overall trend duration is from the start time of tracking to the end time of tracking.

[0149] The physiological sign parameters displayed in the tracking trend graph include but are not limited to the physiological sign parameters corresponding to the target tracking task, and other current physiological sign parameters or non-physiological sign parameters can be added to facilitate medical staff to compare the trend and fluctuation range of physiological sign parameters. At the same time, the tracking trend graph can also support the trend curves of physiological sign parameters of multiple groups of related tasks displayed on the same coordinates.

[0150] In addition, the presentation method of the tracking trend graph is not limited to the trend curve. In some specific embodiments, a histogram (such as Figure 6 ), distribution map (such as Figure 7 ) and other forms to present the distribution of the target physiological sign parameters of the monitored objects at different stages, so that medical staff can fully understand the physiological conditions of the monitored objects during the medication stage.

[0151] In some optional embodiments, a baseline control is provided in the tracking trend display area, and the above step S2052 may further include: in response to a start operation or a close operation of the baseline control, displaying the tracking baseline in the tracking trend display area based on the start operation, or hiding the tracking baseline in the tracking trend display area based on the close operation.

[0152] The tracking baseline can be a starting monitoring value or a target monitoring value, which is not specifically limited here. By setting a baseline control 2121 in the tracking trend display area 212 to turn on or off the same-screen display of the tracking baseline, it is convenient to set the tracking baseline in stages during the medication stage, so that medical staff can intuitively understand the changing state of physiological sign parameters through the tracking baseline.

[0153] In some optional embodiments, a cursor control is provided in the tracking trend display area, and the above step S2052 may further include:

[0154] Step D1, in response to a movement operation on a cursor control, determining a target monitoring point where the cursor is currently located based on the movement operation;

[0155] Step D2, displaying the target parameter value corresponding to the target monitoring point.

[0156] The parameter trend graph displayed in the tracking trend display area 212 supports the review operation of the target monitoring point to determine the target parameter value corresponding to the target monitoring point at the moment, which can be specifically achieved by setting the cursor control 2122.

[0157] Specifically, Figure 3 Taking the tracking trend curve shown as an example, the monitoring device can respond to the medical staff's movement operation on the cursor control 2122 to obtain the positioning time of the cursor control 2122 in the tracking trend curve, and the processor 110 can search the memory 140 for the corresponding parameter data file and return the target parameter value at the positioning time. The tracking trend display area can display the target parameter value at the positioning time, the difference between the target parameter value and the tracking baseline, the current cumulative medication amount, etc. The display content is not specifically limited here and can be set according to actual conditions.

[0158] The difference between the target parameter value and the tracking baseline supports the distinction between increase and decrease. The target parameter value display at the time of positioning includes pop-up window display, floating label display, etc.

[0159] It should be noted that, in order to facilitate the operation of medical staff, the cursor control 2122 here can also support gestures, remote control, clicks and other controls. For example, the cursor control 2122 supports gesture sliding or gradual adjustment, and the parameter trend graph displayed in the tracking trend display area 212 supports gesture sliding page turning, multi-finger zooming, etc.

[0160] Here, the target parameter value of the target monitoring point is determined by moving the cursor control, so that the medical staff can review the target parameter value corresponding to the target monitoring point.

[0161] The monitoring method provided by the embodiment of the present invention supports the creation of target tracking tasks, which is convenient for medical staff to set tracking tasks for the medication stage according to the actual medication situation, and realizes the flexible creation of tracking tasks. By analyzing the changing trend of physiological sign parameters to obtain corresponding fluctuation data, the abnormal data and standard data within the preset tracking time can be counted in combination with the fluctuation data. Then, the abnormal data and standard data are weighted and counted to obtain the corresponding tracking analysis results. In this way, the influence of multiple parameters on physiological sign parameters can be evaluated, and the changing state of physiological sign parameters in the medication stage can be described by tracking and analyzing the results, which realizes automatic analysis of physiological sign parameters, and facilitates medical staff to evaluate the effectiveness of current medication for the monitored object. It supports digital display and graphical display of tracking and analysis results, which is convenient for medical staff to analyze the physiological state of the monitored object from quantitative and qualitative perspectives respectively.

[0162] In this embodiment, a monitoring device is also provided, which is used to implement the above-mentioned embodiments and preferred implementation modes, and the descriptions that have been made will not be repeated. As used below, the term "module" can implement a combination of software and / or hardware of a predetermined function. Although the devices described in the following embodiments are preferably implemented in software, the implementation of hardware, or a combination of software and hardware, is also possible and conceivable.

[0163] This embodiment provides a monitoring device, such as Figure 8 As shown, including:

[0164] The monitoring interface display module 301 is used to display the monitoring interface of the drug tracking task. The monitoring interface includes a tracking task display area and a tracking task data display area. The tracking task display area includes at least one group of tracking tasks.

[0165] The task creation module 302 is used to determine a target tracking task in response to a selection operation and / or a creation operation on a tracking task.

[0166] The task starting module 303 is used to respond to the starting operation of the target tracking task and execute the target tracking task based on the starting operation.

[0167] The parameter monitoring module 304 is used to obtain the physiological sign parameters of the monitored object for the target tracking task, analyze the physiological sign parameters, and obtain the tracking analysis results.

[0168] The tracking result display module 305 is used to display the tracking analysis results in the tracking task data display area.

[0169] In some optional implementations, a sorting control is provided in the tracking task display area. Accordingly, the monitoring device may further include:

[0170] The sequence updating module is used to respond to a first triggering operation on the sorting control and update the display sequence of each group of tracking tasks based on the first triggering operation.

[0171] In some optional implementations, a task start and stop control is provided in the tracking task display area. Accordingly, the monitoring device may further include:

[0172] The task suspension control unit is used to, when the target tracking task is in a tracking state, respond to a second trigger operation on the task start / stop control and suspend the target tracking task based on the second trigger operation.

[0173] The task start control unit is used to start the target tracking task based on the third trigger operation in response to the third trigger operation on the task start / stop control when the target tracking task is in a paused state.

[0174] In some optional implementations, a task association control is provided in the tracking task display area. Accordingly, the monitoring device may further include:

[0175] The association triggering module is used to respond to a fourth triggering operation on the task association control and display an association creation interface based on the fourth triggering operation, wherein at least one task to be associated is displayed in the association creation interface.

[0176] The associated task selection module is used to determine a target associated task from at least one task to be associated in response to a selection operation on the task to be associated.

[0177] The association module is used to bidirectionally bind the target association task with the target tracking task.

[0178] The associated display module is used to display the target tracking task and the target associated task in the tracking task display area according to a preset arrangement order, and to display the tracking data of the target tracking task and the target associated task in the tracking task data display area.

[0179] The association removal module is used to respond to the association removal operation on the target association task and the target tracking task, and unbind the target association task from the target tracking task based on the association removal operation.

[0180] The data update module is used to update the associated tasks of the target tracking task and update the tracking data displayed in the tracking task data display area.

[0181] In some optional embodiments, the task creation module 302 includes:

[0182] The task selection unit is used to determine the target tracking task in response to the selection operation of the tracking task.

[0183] The task triggering unit is used to respond to a fifth triggering operation on the task creation control and display a tracking task creation interface based on the fifth triggering operation, wherein the tracking task creation interface includes a plurality of parameter editing areas.

[0184] The parameter editing unit is used to respond to input operations on each parameter editing area and determine the tracking task parameters based on the input operations.

[0185] The task creation unit is used to create a target tracking task based on the tracking task parameters and display the target tracking task in the tracking task display area.

[0186] In some optional implementations, a template option is provided in the parameter editing area. Accordingly, the task creation module 302 may further include:

[0187] The template selection unit is used to respond to the template selection operation in the parameter editing area and determine the target creation template of the tracking task based on the template selection operation.

[0188] In some optional embodiments, the monitoring device may further include:

[0189] The creation instruction receiving module is used to receive a creation instruction for a tracking task sent by an external device, and the external device is communicatively connected with the monitoring device.

[0190] The information acquisition module is used to acquire the drug infusion information corresponding to the creation instruction and the attribute information of the monitoring object, and the drug infusion information is associated with the attribute information.

[0191] The tracking task creation module is used to obtain a drug tracking template based on a creation instruction, and use the drug tracking template to create a target tracking task for monitoring objects and drug infusion information.

[0192] In some optional implementations, the parameter monitoring module 304 may include:

[0193] The trend analysis module is used to analyze the changing trend of the physiological sign parameters and determine the fluctuation data of the physiological sign parameters.

[0194] The fluctuation analysis module is used to analyze the fluctuation data within the preset tracking time and determine the abnormal data and standard data of the physiological sign parameters.

[0195] The result generation module is used to perform weighted processing on abnormal data and standard data to generate tracking analysis results.

[0196] In some optional implementations, the tracking task data display area includes a tracking trend display area and a tracking data display area. Accordingly, the tracking result display module 305 may include:

[0197] The digital display unit is used to display the tracking analysis results in a digital form in the tracking data display area.

[0198] The graphic display unit is used to display the tracking analysis results in a graphical form in the tracking trend display area.

[0199] In some optional embodiments, a baseline control is provided in the tracking trend display area, and the graphic display unit may include:

[0200] The baseline control subunit is used to respond to a start operation or a close operation of the baseline control, and to display the tracking baseline in the tracking trend display area based on the start operation, or to hide the tracking baseline in the tracking trend display area based on the close operation.

[0201] In some optional embodiments, a cursor control is provided in the tracking trend display area, and the graphic display unit may include:

[0202] The cursor moving unit is used to respond to the moving operation of the cursor control and determine the target monitoring point where the cursor is currently located based on the moving operation.

[0203] The parameter value display unit is used to display the target parameter value corresponding to the target monitoring point.

[0204] The further functional description of the above modules and units is the same as that of the above corresponding embodiments and will not be repeated here.

[0205] The monitoring device in this embodiment is presented in the form of a functional unit, where the unit refers to an ASIC circuit, a processor and a memory that executes one or more software or fixed programs, and / or other devices that can provide the above functions.

[0206] The monitoring device provided by the embodiment of the present invention displays the tracking task for the monitored object in the tracking task display area of ​​the monitoring interface, and obtains the physiological sign parameters corresponding to the target tracking task in real time by selecting the target tracking task, and analyzes the physiological sign parameters to obtain the drug tracking analysis results, thereby avoiding manual retrieval and manual statistics of physiological abnormal events, and realizing real-time tracking of physiological sign parameters and automatic analysis of physiological sign parameters. At the same time, the tracking analysis results are displayed in the tracking task data display area, which is convenient for medical staff to intuitively understand the dynamic changes of physiological sign parameters during the medication stage.

[0207] The embodiment of the present invention also provides a computer-readable storage medium. The method according to the embodiment of the present invention can be implemented in hardware, firmware, or can be implemented as a computer code that can be recorded in a storage medium, or can be implemented as a computer code that is originally stored in a remote storage medium or a non-temporary machine-readable storage medium and will be stored in a local storage medium through a network download, so that the method described herein can be stored in such software processing on a storage medium using a general-purpose computer, a dedicated processor, or programmable or dedicated hardware. Among them, the storage medium can be a magnetic disk, an optical disk, a read-only storage memory, a random access memory, a flash memory, a hard disk or a solid-state hard disk, etc.; further, the storage medium can also include a combination of the above types of memories. It can be understood that a computer, a processor, a microprocessor controller, or programmable hardware includes a storage component that can store or receive software or computer code. When the software or computer code is accessed and executed by a computer, a processor, or hardware, the method shown in the above embodiment is implemented.

[0208] Although the embodiments of the present invention have been described in conjunction with the accompanying drawings, those skilled in the art may make various modifications and variations without departing from the spirit and scope of the present invention, and such modifications and variations are all within the scope defined by the appended claims.

Claims

1. A monitoring method, used in a monitoring device, characterized in that: The method comprises: A monitoring interface for displaying drug tracking tasks, the monitoring interface comprising a tracking task display area and a tracking task data display area, the tracking task display area comprising at least one group of tracking tasks; In response to a selection operation and / or a creation operation on the tracking task, determining a target tracking task; In response to a start operation on the target tracking task, executing the target tracking task based on the start operation; Acquiring physiological sign parameters of the monitored object for the target tracking task, analyzing the physiological sign parameters, and obtaining tracking analysis results; The tracking analysis result is displayed in the tracking task data display area.

2. The method according to claim 1, characterized in that The tracking task display area includes a sorting control, and the method further includes: In response to a first trigger operation on the sorting control, a display order of each group of tracking tasks is updated based on the first trigger operation.

3. The method according to claim 2, characterized in that The tracking task display area also includes a task start and stop control, and the method further includes: When the target tracking task is in a tracking state, in response to a second trigger operation on the task start / stop control, pausing the target tracking task based on the second trigger operation; When the target tracking task is in a paused state, in response to a third trigger operation on the task start / stop control, the target tracking task is started based on the third trigger operation.

4. The method according to claim 2 or 3, characterized in that: The tracking task display area also includes a task association control, and the method further includes: In response to a fourth trigger operation on the task association control, displaying an association creation interface based on the fourth trigger operation, wherein at least one task to be associated is displayed in the association creation interface; In response to a selection operation on the task to be associated, determining a target associated task from the at least one task to be associated; Bidirectionally binding the target association task with the target tracking task; The target tracking task and the target association task are displayed in the tracking task display area according to a preset arrangement order, and the tracking data of the target tracking task and the target association task are displayed in the tracking task data display area.

5. The method according to claim 4, characterized in that Also includes: In response to a disassociation operation on the target association task and the target tracking task, unbinding the target association task from the target tracking task based on the disassociation operation; The associated tasks of the target tracking task are updated, and the tracking data displayed in the tracking task data display area is updated.

6. The method according to claim 1, characterized in that The tracking task display area includes a task creation control; In response to the creation operation of the tracking task, determining the target tracking task includes: In response to a fifth trigger operation on the task creation control, displaying a tracking task creation interface based on the fifth trigger operation, the tracking task creation interface including a plurality of parameter editing areas; In response to input operations on each of the parameter editing areas, determining tracking task parameters based on the input operations; The target tracking task is created based on the tracking task parameters, and the target tracking task is displayed in the tracking task display area.

7. The method according to claim 6, characterized in that Also includes: In response to a template selection operation in the parameter editing area, a target creation template for the tracking task is determined based on the template selection operation.

8. The method according to claim 1, characterized in that Also includes: Receiving a creation instruction for the tracking task sent by an external device, the external device being communicatively connected with the monitoring device; Acquire drug infusion information corresponding to the creation instruction and attribute information of the monitored object, wherein the drug infusion information is associated with the attribute information; A drug tracking template is obtained based on the creation instruction, and a target tracking task for the monitored object and the drug infusion information is created using the drug tracking template.

9. The method according to claim 1, characterized in that: The step of obtaining the physiological sign parameters of the monitored object for the target tracking task, analyzing the physiological sign parameters, and obtaining the tracking analysis results includes: Analyze the change trend of the physiological sign parameters to determine the fluctuation data of the physiological sign parameters; Analyze the fluctuation data within the preset tracking time to determine the abnormal data and standard data of the physiological sign parameters; The abnormal data and the standard-compliant data are weighted to generate the tracking and analysis result.

10. The method according to claim 9, characterized in that The tracking task data display area includes a tracking trend display area and a tracking data display area, and the tracking analysis results are displayed in the tracking task data display area, including: Displaying the tracking analysis results in digital form in the tracking data display area; The tracking analysis result is displayed in a graphical form in the tracking trend display area.

11. The method according to claim 10, characterized in that The tracking trend display area includes a baseline control, and the method further includes: In response to a start operation or a close operation on the baseline control, the tracking baseline is displayed in the tracking trend display area based on the start operation, or the tracking baseline in the tracking trend display area is hidden based on the close operation.

12. The method according to claim 10 or 11, characterized in that: The tracking trend display area includes a cursor control, and the method further includes: In response to a movement operation on the cursor control, determining a target monitoring point where the cursor is currently located based on the movement operation; The target parameter value corresponding to the target monitoring point is displayed.

13. A monitoring system, characterized in that: The system comprises: A monitoring interface display module, used to display a monitoring interface of a drug tracking task, wherein the monitoring interface includes a tracking task display area and a tracking task data display area, wherein the tracking task display area includes at least one group of tracking tasks; A task creation module, configured to determine a target tracking task in response to a selection operation and / or a creation operation on the tracking task; A task starting module, configured to respond to a starting operation on the target tracking task and execute the target tracking task based on the starting operation; A parameter monitoring module is used to obtain the physiological sign parameters of the monitored object for the target tracking task, analyze the physiological sign parameters, and obtain tracking analysis results; The tracking result display module is used to display the tracking analysis result in the tracking task data display area.

14. A monitoring device, characterized in that: include: A memory and a processor, wherein the memory and the processor are communicatively connected to each other, the memory stores computer instructions, and the processor executes the monitoring method according to any one of claims 1 to 12 by executing the computer instructions.

15. A computer-readable storage medium, characterized in that: The computer-readable storage medium stores computer instructions, and the computer instructions are used to enable a computer to execute the monitoring method according to any one of claims 1 to 12.